SPY389.63+0.17 0.04%
DIA312.42-0.01 0.00%
IXIC11,354.62-33.88 -0.30%

Biogen, Scribe Therapeutics Expand Research Collaboration to Second Disease Target

MT Newswires · 05/02/2022 07:10

Please log in to view news